1-Diphenylmethyl-3-cyanoazetidine

1-Diphenylmethyl-3-cyanoazetidine
Product Description

PharmaBlock provides wide range of pharmaceutical products which includes1-Diphenylmethyl-3-cyanoazetidine. Storage:>200kg. Contact us for more information.

PharmaBlock Sciences(Nanjing),Inc.

  • CN
  • 2016
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Primary activities
API Producer
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Specifications
  • Selling Points
    Experienced Technicians; International Approvals/Standards; Quality Service; Reputation
  • Supplied from
    China
  • Measured In
    kilogram

PharmaBlock Sciences(Nanjing),Inc.

  • CN
  • 2016
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Primary activities
API Producer
Chemical Development
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis

More Products from PharmaBlock Sciences(Nanjing),Inc. (17)

PharmaBlock Sciences(Nanjing),Inc. resources (3)

  • News PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

    PharmaBlock has been selected as the winner of the 2023 CMO Excellence in Green Chemistry Award by the American Chemical Society (ACS) Green Chemistry Institute Pharmaceutical Roundtable (GCI PR). This award honors and confirms PharmaBlock’s commitment to green chemistry and its achievement in developing innovative solutions for sustainable development in the pharmaceutical industry.
  • Video Innovation at PharmaBlock

    Innovation at PharmaBlock
  • Video Innovation for Sustainability: A Dive Into ACS Green Chemistry Award-Winning Continuous Flow Manufacturing Case Studies

    To improve pharmaceutical supply chain sustainability, it is crucial to place green chemistry and low-carbon technologies, including but not limited to continuous flow chemistry, and biocatalysis, at the forefront of the industry’s sustainability efforts. PharmaBlock's award-winning projects, recognized by the 2023 and 2024 ACS CMO Excellence in Green Chemistry Award, exemplify these sustainable advancements with such innovative technologies. Key discussion points include: 1. Maximizing Sustainability Returns: Enhancing the environmental performance of raw materials and RSMs is crucial for achieving the highest sustainability returns. These intermediates often have a substantial environmental footprint, as their production processes may not be as optimized as those of upstream steps, and they are produced at larger scales compared to downstream processes. 2. Overcoming Flow Technology Challenges: The application of flow technology, especially in hydrogenation and other heterogeneous reactions, presents significant challenges. These include the need for substantial investment in specialized equipment, the development of immobilized catalyst technology, and the integration of process analytical technology. 3. The environmental implications of these